360 related articles for article (PubMed ID: 19880791)
1. Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly.
Ueland T; Fougner SL; Godang K; Lekva T; Schurgers LJ; Scholz H; Halvorsen B; Schreiner T; Aukrust P; Bollerslev J
J Clin Endocrinol Metab; 2010 Jan; 95(1):361-8. PubMed ID: 19880791
[TBL] [Abstract][Full Text] [Related]
2. Adipocytes as a source of increased circulating levels of nicotinamide phosphoribosyltransferase/visfatin in active acromegaly.
Olarescu NC; Ueland T; Lekva T; Dahl TB; Halvorsen B; Aukrust P; Bollerslev J
J Clin Endocrinol Metab; 2012 Apr; 97(4):1355-62. PubMed ID: 22319029
[TBL] [Abstract][Full Text] [Related]
3. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
[TBL] [Abstract][Full Text] [Related]
4. Serum GH and IGF-I are significant determinants of bone turnover but not bone mineral density in active acromegaly: a prospective study of more than 70 consecutive patients.
Ueland T; Fougner SL; Godang K; Schreiner T; Bollerslev J
Eur J Endocrinol; 2006 Nov; 155(5):709-15. PubMed ID: 17062887
[TBL] [Abstract][Full Text] [Related]
5. Serum osteocalcin is associated with improved metabolic state via adiponectin in females versus testosterone in males. Gender specific nature of the bone-energy homeostasis axis.
Buday B; Pach FP; Literati-Nagy B; Vitai M; Vecsei Z; Koranyi L
Bone; 2013 Nov; 57(1):98-104. PubMed ID: 23886839
[TBL] [Abstract][Full Text] [Related]
6. A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly.
Sucunza N; Barahona MJ; Resmini E; Fernández-Real JM; Ricart W; Farrerons J; Rodríguez Espinosa J; Marin AM; Puig T; Webb SM
J Clin Endocrinol Metab; 2009 Oct; 94(10):3889-96. PubMed ID: 19723758
[TBL] [Abstract][Full Text] [Related]
7. The Metabolic Risk in Patients Newly Diagnosed with Acromegaly Is Related to Fat Distribution and Circulating Adipokines and Improves after Treatment.
Olarescu NC; Heck A; Godang K; Ueland T; Bollerslev J
Neuroendocrinology; 2016; 103(3-4):197-206. PubMed ID: 25592241
[TBL] [Abstract][Full Text] [Related]
8. IGF-I/IGF-binding protein-3 combination improves insulin resistance by GH-dependent and independent mechanisms.
O'Connell T; Clemmons DR
J Clin Endocrinol Metab; 2002 Sep; 87(9):4356-60. PubMed ID: 12213898
[TBL] [Abstract][Full Text] [Related]
9. Effect of growth hormone (GH) on serum concentrations of leptin: study in patients with acromegaly and GH deficiency.
Miyakawa M; Tsushima T; Murakami H; Isozaki O; Demura H; Tanaka T
J Clin Endocrinol Metab; 1998 Oct; 83(10):3476-9. PubMed ID: 9768649
[TBL] [Abstract][Full Text] [Related]
10. Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients.
Ciresi A; Amato MC; Pizzolanti G; Giordano Galluzzo C
J Clin Endocrinol Metab; 2012 Aug; 97(8):2907-15. PubMed ID: 22679062
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory adipokines contribute to insulin resistance in active acromegaly and respond differently to different treatment modalities.
Olarescu NC; Ueland T; Godang K; Lindberg-Larsen R; Jørgensen JO; Bollerslev J
Eur J Endocrinol; 2014 Jan; 170(1):39-48. PubMed ID: 24092547
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
[TBL] [Abstract][Full Text] [Related]
13. [Serum adiponectin levels in patients with acromegaly].
Siemińska L; Lenart J; Cichoń-Lenart A; Niedziołka D; Marek B; Kos-Kudła B; Kajdaniuk D; Nowak M
Pol Merkur Lekarski; 2005 Oct; 19(112):514-6. PubMed ID: 16379314
[TBL] [Abstract][Full Text] [Related]
14. Serum leptin levels in acromegaly--a significant role for adipose tissue and fasting insulin/glucose ratio.
Bolanowski M; Milewicz A; Bidzińska B; Jedrzejuk D; Daroszewski J; Mikulski E
Med Sci Monit; 2002 Oct; 8(10):CR685-9. PubMed ID: 12388920
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition.
De Marinis L; Bianchi A; Mancini A; Gentilella R; Perrelli M; Giampietro A; Porcelli T; Tilaro L; Fusco A; Valle D; Tacchino RM
J Clin Endocrinol Metab; 2004 Jan; 89(1):174-80. PubMed ID: 14715846
[TBL] [Abstract][Full Text] [Related]
16. Effects of GH-IGF-I excess and gonadal status on bone mineral density and body composition in patients with acromegaly.
Madeira M; Neto LV; de Lima GA; Moreira RO; de Mendonça LM; Gadelha MR; Farias ML
Osteoporos Int; 2010 Dec; 21(12):2019-25. PubMed ID: 20306022
[TBL] [Abstract][Full Text] [Related]
17. Modulation of cortisol metabolism during treatment of acromegaly is independent of body composition and insulin sensitivity.
Frajese GV; Taylor NF; Jenkins PJ; Besser GM; Monson JP
Horm Res; 2004; 61(5):246-51. PubMed ID: 15004437
[TBL] [Abstract][Full Text] [Related]
18. Serum leptin levels in patients with acromegaly before and after correction of hypersomatotropism by trans-sphenoidal surgery.
Damjanović SS; Petakov MS; Raicević S; Micić D; Marinković J; Dieguez C; Casanueva FF; Popović V
J Clin Endocrinol Metab; 2000 Jan; 85(1):147-54. PubMed ID: 10634378
[TBL] [Abstract][Full Text] [Related]
19. Body Composition and Ectopic Lipid Changes With Biochemical Control of Acromegaly.
Bredella MA; Schorr M; Dichtel LE; Gerweck AV; Young BJ; Woodmansee WW; Swearingen B; Miller KK
J Clin Endocrinol Metab; 2017 Nov; 102(11):4218-4225. PubMed ID: 28945897
[TBL] [Abstract][Full Text] [Related]
20. The impact of pegvisomant treatment on substrate metabolism and insulin sensitivity in patients with acromegaly.
Lindberg-Larsen R; Møller N; Schmitz O; Nielsen S; Andersen M; Orskov H; Jørgensen JO
J Clin Endocrinol Metab; 2007 May; 92(5):1724-8. PubMed ID: 17341562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
